JSP 507 (Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg)
Pill with imprint JSP 507 is Blue & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg. It is supplied by Lannett Company, Inc..
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for JSP 507
Aspirin, Butalbital, Caffeine and Codeine
- Imprint
- JSP 507
- Strength
- 325 mg / 50 mg / 40 mg / 30 mg
- Color
- Blue & Yellow
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Lannett Company, Inc.
- Inactive Ingredients
-
D&C Yellow No. 10, aluminum oxide, D&C Red No. 33, D&C Red No. 28, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, microcrystalline cellulose, corn starch, magnesium silicate, titanium dioxide, stearic acid, silicon dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00527-1312 | Lannett Company, Inc. |
63874-0219 | Altura Pharmaceuticals Inc. (repackager) |
More about aspirin / butalbital / caffeine / codeine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 29 Reviews
- Drug class: narcotic analgesic combinations
- FDA Alerts (5)
Consumer resources
- Aspirin, butalbital, caffeine, and codeine
- Butalbital, aspirin, caffeine, and codeine (Advanced Reading)
- Butalbital, Aspirin, Caffeine, and Codeine
Other brands: Fiorinal with Codeine, Ascomp with Codeine, Fiorinal with Codeine III
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.